Trump signed an EO to reschedule cannabis, lifting 280E taxes for US MSOs like Cresco Labs, as shares fell on profit taking. Read why CRLBF stock is a hold.

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients.

The move wouldn't legalize marijuana, but moving it from Schedule I to Schedule III would allow the FDA to study it for medical purposes.

Starting next month, Howard County’s first responders will be allowed to use medically prescribed cannabis off-duty, County Executive Calvin Ball announced Friday. The union that represents

U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here’s a look at what that would mean for people shopping at dispensaries across the country.

Innovative Industrial trades at just 0.74x tangible book and 7.4x AFFO, with a robust 14.3% dividend yield. Read why IIPR stock is a Strong Buy.

Rob Van Dam is thrilled with the “birthday present” that Donald Trump just gave him. RVD’s birthday is8. That also happens to be the same day that United States President Donald Trump signed an executive order that reclassified cannabis as a Schedule 3 controlled substance.

But the Cannabis Control Commission says the report lacks a causal link between commercialization and the uptick in marijuana-related youth psychosis. The post MGH study links cannabis commercialization and teen psychiatric emergencies appeared first on Boston.

Shares of some cannabis firms fell between 3% and 12% at Thursday's close, erasing previous gains from the session, after U.S. President Donald Trump signed an executive order recommending the loosening of federal regulations on marijuana.